XML 72 R62.htm IDEA: XBRL DOCUMENT v3.24.2.u1
COMMITMENTS AND CONTINGENCIES (Details)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 27, 2023
USD ($)
Dec. 03, 2020
plaintiff
Jan. 31, 2024
claim
Dec. 31, 2023
claim
Sep. 30, 2022
claim
Jun. 30, 2024
USD ($)
product
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
product
Jun. 30, 2023
USD ($)
Dec. 31, 2012
manufacturer
Mar. 04, 2024
Apr. 30, 2023
COMMITMENTS AND CONTINGENCIES                        
Lease term                       5 years
Number of products marketed without approved NDAs or ANDAs | product           4   4        
Total net revenues           $ 138,040 $ 116,547 $ 275,470 $ 223,333      
Payment for acquired intangible assets               0 4,329      
Number of plaintiffs | plaintiff   6                    
Number of potential manufacturers | manufacturer                   7    
Royalty percentage                     5.00%  
Net sales percentage                     5.00%  
Number of complaints filed | claim     1 200 2              
Alvogen Inc | Product Intellectual Property                        
COMMITMENTS AND CONTINGENCIES                        
Payment for acquired intangible assets $ 2,000                      
Novitium                        
COMMITMENTS AND CONTINGENCIES                        
Number of complaints filed | claim       28                
Unapproved Products                        
COMMITMENTS AND CONTINGENCIES                        
Total net revenues           6,800 3,500 10,900 7,200      
Unapproved Products | Contract Customer                        
COMMITMENTS AND CONTINGENCIES                        
Total net revenues           $ 100 $ 500 $ 100 $ 1,100